Nova Eye Medical Ltd · ASX:EYE
Nova Eye Medical — Hidden Gems Webinar 2023
15 slides from Nova Eye Medical's conference presentation, May 19, 2023
Slide 1: Hidden Gems Webinar: Addressing the Leading Causes of Blindness
Hidden Gems Webinar, May 19, 2023 “Addressing the Leading Causes of Blindness” Nova Eye Medical Limited (ASX:EYE)
Slide 2: Disclaimer
DISCLAIMER This presentation has been prepared by Nova Eye Medical Limited (ASX: EYE). While the information in this presentation has been prepared in good faith and with reasonable care, no representation or warranty, express or implied, is made as to the accuracy, adequacy or reliability of any st
Slide 3: Business Snapshot
BUSINESS SNAPSHOT Nova Eye Medical leads the way in interventional treatment solutions for glaucoma and age-related macular degeneration (AMD), the leading causes of blindness in the developed world. Nova Eye Medical, Glaucoma AlphaRET, AMD Develop, market and sell comprehensive portfolio Strategy P
Slide 4: Company Overview
COMPANY OVERVIEW Capital Structure Share Price Chart ASX Code EYE 6,000,000 $0.35 Share Price (at 16 May 2023) $0.225 Shares on Issue 190 M 5,000,000 $0.30 Unlisted Options (unquoted securities) 3.35 M Market Capitalisation $42.8 M 4,000,000 $0.25 Cash (31 December*) $11M 3,000,000 Top 20 Shareholde
Slide 5: Our Glaucoma Opportunity
OUR GLAUCOMA OPPORTUNITY • With a proprietary product portfolio and an established glaucoma salesforce, Established glaucoma salesforce in Nova Eye Medical is well positioned to the USA – the world’s largest market execute its glaucoma opportunity. for ophthalmology. • The new iTrack™ Advance canalo
Slide 6: Glaucoma, Disease Overview
GLAUCOMA, DISEASE OVERVIEW • Glaucoma is the leading cause of blindness in the developed world • Progressive, irreversible eye disease that causes vision loss due to optic nerve damage. • Elevated intraocular pressure (IOP) is the most significant risk factor for the development of glaucoma. 2 • The
Slide 7: Glaucoma, Treatment Overview
GLAUCOMA, TREATMENT OVERVIEW • Traditional treatment paradigm consisted of long-term chronic medication use. Patient adherence to glaucoma medications is poor • Patients and surgeons are moving away 10-25% of newly prescribed patients don’t refill from medications in favour of minimally second presc
Slide 8: Glaucoma, Market Overview
GLAUCOMA, MARKET OVERVIEW • The glaucoma consumable surgical devices market is the fastest growing US$667m segment of the ophthalmic market. CAGR 15% • The aging global population drives 144.2 Glaucoma Surgical Device market size and growth rate prevalence, representing a significant million per ann
Slide 9: Glaucoma, by Geography
GLAUCOMA, BY GEOGRAPHY China Improved access to healthcare driving surgeon demand Well networked distribution US$37 partner with direct sales force million growing at 31%1 Germany USA Nova Eye Medical Nova Eye, Inc GmbH New Zealand Molteno Ophthalmic Ltd World’s largest market for German sales team
Slide 10: iTrack Advance
10 iTrack™ Advance • Our iTrack™ Advance MIGS device is redefining the treatment of glaucoma in its early stages. • Enhanced version of our original iTrack™ microcatheter, which was first brought to market in 2008 and has been used in more than 120,000 procedures globally. • Offers a stent-free, tis
Slide 11: iTrack Advance
11 iTrack™ Advance NEW IMAGE REQUIRED 3 2 1
Slide 12: iTrack Advance
12 iTrack™ Advance
Slide 13: In the USA, iTrack is regularly used by approx. 200 specialist glaucoma surgeons
In the USA, iTrack™ is regularly used by 200 1,3001 approx. 200 specialist glaucoma surgeons. existing surgeon estimated The new iTrack™ Advance will appeal to the customers glaucoma surgeon market additional 1,100 glaucoma surgeons and the additional 10,000 comprehensive and cataract surgeons. “iTr
Slide 14: Our Glaucoma Outlook
OUR GLAUCOMA OUTLOOK 1 Glaucoma consumable surgical devices represent the fastest growing market in ophthalmology. 2 Best-in-class iTrack™ Advance device approved for sale in the USA, the world’s largest market. 3 Established, scalable glaucoma salesforce and commercial infrastructure in USA. 4 Well
Slide 15: Nova Eye Medical
ac NOVAEYE MEDICAL.